• Active Ingredients Market Size To Grow At A CAGR Of 5.2% In The Forecast Period Of 2025-2032

    Active Ingredients Market is projected to grow from USD 266.4 billion in 2023 to USD 389.2 billion by 2030, registering a healthy CAGR of 5.5% during the forecast period. The market is being fueled by expanding pharmaceutical and cosmetic industries, growing demand for personalized medicine, clean-label beauty products, and rising agricultural efficiency needs.

    Request Free Sample Report:https://www.stellarmr.com/report/req_sample/Active-Ingredients-Market/153

    Market Estimation, Growth Drivers & Opportunities
    Active ingredients (AIs) are the biologically active components in pharmaceutical drugs, cosmetics, and agrochemicals that directly impact therapeutic or functional outcomes. Their development, purity, and efficacy are central to innovation across multiple industries.

    Key Growth Drivers:

    Rising Global Healthcare Needs: With aging populations and increased prevalence of chronic diseases, demand for novel and effective active pharmaceutical ingredients (APIs) is surging.

    Boom in Cosmetics and Personal Care: Active ingredients like retinol, peptides, and hyaluronic acid are at the core of skincare innovation, especially in anti-aging and skin-brightening segments.

    Increased Agricultural Productivity Demands: Crop protection products and fertilizers are increasingly dependent on high-performance active ingredients to ensure yield in challenging climatic conditions.

    Clean Label and Natural Trends: Across beauty and nutraceuticals, the push for naturally derived active ingredients is creating strong demand for plant-based or organic formulations.

    Emerging Opportunities:

    Biotechnology-Based APIs: The emergence of biopharmaceuticals and biosimilars is driving demand for complex biological active ingredients.

    Green Chemistry and Sustainable Production: Environmentally friendly synthesis methods are being adopted in pharmaceutical and agrochemical manufacturing.

    Personalized Formulations: Tailored active ingredient blends for individuals based on skin type, genetic profile, or health status are gaining popularity in high-end consumer segments.

    U.S. Market Trends and 2024 Investment Insights
    In 2024, the United States witnessed substantial investment in biologics manufacturing and cosmetic R&D. The Inflation Reduction Act's provisions for local drug manufacturing boosted domestic production of APIs, reducing dependency on imports. Simultaneously, major skincare brands and biotech firms announced collaborations to develop cruelty-free, lab-grown active ingredients, aligning with ethical and clean beauty movements. Consumer demand for functional cosmetics and supplements with proven clinical efficacy significantly elevated the use of advanced actives across product categories.

    Market Segmentation – Leading Segments by Market Share
    By Source:

    Synthetic Active Ingredients continue to dominate the pharmaceutical and agrochemical industries due to scalability and stability.

    Natural Active Ingredients are gaining rapid traction in the cosmetics and nutraceutical sectors, favored for their biocompatibility and safety perception.

    By Application:

    Pharmaceuticals lead the global market, accounting for the largest share due to the critical importance of APIs in drug formulation and therapy.

    Cosmetics is the fastest-growing segment, driven by rising consumer awareness, global K-beauty influence, and product personalization.

    Agrochemicals also contribute significantly, especially in regions emphasizing sustainable agriculture and pest control solutions.

    By End User:

    B2B Manufacturers such as contract manufacturing organizations (CMOs) and ingredient suppliers dominate the supply side.

    Consumer Brands are increasingly formulating in-house or partnering with biotech firms to innovate new actives aligned with evolving trends.

    Competitive Landscape – Top 5 Global Companies Shaping the Market
    1. BASF SE
    BASF remains a global leader in active ingredients for cosmetics and agriculture. In 2024, the company launched several new bio-based actives for anti-pollution skincare and pesticide formulations that reduce environmental runoff.

    2. Lonza Group AG
    A major player in pharmaceutical APIs and biotechnology, Lonza expanded its biopharma capacity in Asia and North America to meet increasing demand for biologic-based active ingredients.

    3. Evonik Industries
    Evonik is renowned for its skin actives and formulation technologies. In 2024, the company introduced peptide-based ingredients tailored for regenerative and anti-aging skincare.

    4. Croda International Plc
    Croda focuses on cosmetic and health care actives with strong green chemistry credentials. The company made significant investments in high-performance botanical extraction and launched new vegan-certified actives for sensitive skin.

    5. Syngenta AG
    In the agrochemical sector, Syngenta leads the market with advanced crop protection ingredients. The company’s R&D efforts in 2024 focused on developing dual-action actives that combine pest resistance and plant growth stimulation.

    These market leaders are aligning with global trends in sustainability, digital formulation tracking, and personalized health, investing in eco-conscious manufacturing and strategic partnerships.

    Regional Insights – Key Country Markets and Regulatory Factors
    United States:
    With its strong pharmaceutical base and rising cosmeceutical innovation, the U.S. continues to lead the global market. FDA regulations favor companies with robust clinical data, pushing innovation in safety and efficacy of active ingredients.

    Germany:
    Known for its stringent chemical standards, Germany remains a hub for high-purity APIs and cosmetic actives. The government promotes green chemistry and local production incentives, reinforcing Germany’s leadership in formulation science.

    France:
    France is the global capital for skincare innovation. French cosmetic giants continue to lead in natural and sensorial actives, with heavy investment in R&D for microbiome-friendly ingredients.

    United Kingdom:
    The UK is seeing strong growth in biotech-derived active ingredients post-Brexit, especially through collaborations between academic institutions and life sciences companies focused on dermatology and mental wellness.

    Japan:
    Japan’s tradition of precision skincare and pharmaceutical excellence drives demand for high-quality, function-focused actives. Innovations in anti-aging and brightening actives remain strong due to demographic trends.

    China:
    China’s active ingredient market is growing rapidly across all three verticals. Supportive policies for domestic pharmaceutical production and increasing cosmetic exports are fueling demand for locally produced and compliant actives.

    Conclusion & Strategic Outlook
    The Active Ingredients Market is undergoing a profound transformation as science, sustainability, and personalization converge. Whether enhancing the effectiveness of drugs, improving skincare results, or supporting agricultural yield, active ingredients are at the core of innovation across sectors.

    About us

    Phase 3,Navale IT Zone, S.No. 51/2A/2,

    Office No. 202, 2nd floor,

    Near, Navale Brg,Narhe,

    Pune, Maharashtra 411041

    +91 9607365656

    [email protected]
    Active Ingredients Market Size To Grow At A CAGR Of 5.2% In The Forecast Period Of 2025-2032 Active Ingredients Market is projected to grow from USD 266.4 billion in 2023 to USD 389.2 billion by 2030, registering a healthy CAGR of 5.5% during the forecast period. The market is being fueled by expanding pharmaceutical and cosmetic industries, growing demand for personalized medicine, clean-label beauty products, and rising agricultural efficiency needs. Request Free Sample Report:https://www.stellarmr.com/report/req_sample/Active-Ingredients-Market/153 Market Estimation, Growth Drivers & Opportunities Active ingredients (AIs) are the biologically active components in pharmaceutical drugs, cosmetics, and agrochemicals that directly impact therapeutic or functional outcomes. Their development, purity, and efficacy are central to innovation across multiple industries. Key Growth Drivers: Rising Global Healthcare Needs: With aging populations and increased prevalence of chronic diseases, demand for novel and effective active pharmaceutical ingredients (APIs) is surging. Boom in Cosmetics and Personal Care: Active ingredients like retinol, peptides, and hyaluronic acid are at the core of skincare innovation, especially in anti-aging and skin-brightening segments. Increased Agricultural Productivity Demands: Crop protection products and fertilizers are increasingly dependent on high-performance active ingredients to ensure yield in challenging climatic conditions. Clean Label and Natural Trends: Across beauty and nutraceuticals, the push for naturally derived active ingredients is creating strong demand for plant-based or organic formulations. Emerging Opportunities: Biotechnology-Based APIs: The emergence of biopharmaceuticals and biosimilars is driving demand for complex biological active ingredients. Green Chemistry and Sustainable Production: Environmentally friendly synthesis methods are being adopted in pharmaceutical and agrochemical manufacturing. Personalized Formulations: Tailored active ingredient blends for individuals based on skin type, genetic profile, or health status are gaining popularity in high-end consumer segments. U.S. Market Trends and 2024 Investment Insights In 2024, the United States witnessed substantial investment in biologics manufacturing and cosmetic R&D. The Inflation Reduction Act's provisions for local drug manufacturing boosted domestic production of APIs, reducing dependency on imports. Simultaneously, major skincare brands and biotech firms announced collaborations to develop cruelty-free, lab-grown active ingredients, aligning with ethical and clean beauty movements. Consumer demand for functional cosmetics and supplements with proven clinical efficacy significantly elevated the use of advanced actives across product categories. Market Segmentation – Leading Segments by Market Share By Source: Synthetic Active Ingredients continue to dominate the pharmaceutical and agrochemical industries due to scalability and stability. Natural Active Ingredients are gaining rapid traction in the cosmetics and nutraceutical sectors, favored for their biocompatibility and safety perception. By Application: Pharmaceuticals lead the global market, accounting for the largest share due to the critical importance of APIs in drug formulation and therapy. Cosmetics is the fastest-growing segment, driven by rising consumer awareness, global K-beauty influence, and product personalization. Agrochemicals also contribute significantly, especially in regions emphasizing sustainable agriculture and pest control solutions. By End User: B2B Manufacturers such as contract manufacturing organizations (CMOs) and ingredient suppliers dominate the supply side. Consumer Brands are increasingly formulating in-house or partnering with biotech firms to innovate new actives aligned with evolving trends. Competitive Landscape – Top 5 Global Companies Shaping the Market 1. BASF SE BASF remains a global leader in active ingredients for cosmetics and agriculture. In 2024, the company launched several new bio-based actives for anti-pollution skincare and pesticide formulations that reduce environmental runoff. 2. Lonza Group AG A major player in pharmaceutical APIs and biotechnology, Lonza expanded its biopharma capacity in Asia and North America to meet increasing demand for biologic-based active ingredients. 3. Evonik Industries Evonik is renowned for its skin actives and formulation technologies. In 2024, the company introduced peptide-based ingredients tailored for regenerative and anti-aging skincare. 4. Croda International Plc Croda focuses on cosmetic and health care actives with strong green chemistry credentials. The company made significant investments in high-performance botanical extraction and launched new vegan-certified actives for sensitive skin. 5. Syngenta AG In the agrochemical sector, Syngenta leads the market with advanced crop protection ingredients. The company’s R&D efforts in 2024 focused on developing dual-action actives that combine pest resistance and plant growth stimulation. These market leaders are aligning with global trends in sustainability, digital formulation tracking, and personalized health, investing in eco-conscious manufacturing and strategic partnerships. Regional Insights – Key Country Markets and Regulatory Factors United States: With its strong pharmaceutical base and rising cosmeceutical innovation, the U.S. continues to lead the global market. FDA regulations favor companies with robust clinical data, pushing innovation in safety and efficacy of active ingredients. Germany: Known for its stringent chemical standards, Germany remains a hub for high-purity APIs and cosmetic actives. The government promotes green chemistry and local production incentives, reinforcing Germany’s leadership in formulation science. France: France is the global capital for skincare innovation. French cosmetic giants continue to lead in natural and sensorial actives, with heavy investment in R&D for microbiome-friendly ingredients. United Kingdom: The UK is seeing strong growth in biotech-derived active ingredients post-Brexit, especially through collaborations between academic institutions and life sciences companies focused on dermatology and mental wellness. Japan: Japan’s tradition of precision skincare and pharmaceutical excellence drives demand for high-quality, function-focused actives. Innovations in anti-aging and brightening actives remain strong due to demographic trends. China: China’s active ingredient market is growing rapidly across all three verticals. Supportive policies for domestic pharmaceutical production and increasing cosmetic exports are fueling demand for locally produced and compliant actives. Conclusion & Strategic Outlook The Active Ingredients Market is undergoing a profound transformation as science, sustainability, and personalization converge. Whether enhancing the effectiveness of drugs, improving skincare results, or supporting agricultural yield, active ingredients are at the core of innovation across sectors. About us Phase 3,Navale IT Zone, S.No. 51/2A/2, Office No. 202, 2nd floor, Near, Navale Brg,Narhe, Pune, Maharashtra 411041 +91 9607365656 [email protected]
    0 Bình luận 0 Chia sẻ 2655 Lượt xem
  • Asia Pacific Prefilled Syringes Market Size To Grow At A CAGR Of 11% In The Forecast Period Of 2025-2032

    Asia Pacific Prefilled Syringes Market is projected to surge from USD 1.96 billion in 2023 to USD 3.41 billion by 2030, registering a CAGR of 8.3% over the forecast period. Fueled by a growing elderly population, rapid healthcare infrastructure development, and the increasing use of biologics, prefilled syringes are gaining momentum as a preferred drug delivery method across the region.

    Request Free Sample Report:https://www.stellarmr.com/report/req_sample/Asia-Pacific-Prefilled-Syringes-Market/1779

    Market Estimation, Growth Drivers & Opportunities
    Prefilled syringes have become a critical part of modern healthcare due to their convenience, accuracy, sterility, and reduced risk of contamination and dosing errors. The Asia Pacific region is witnessing substantial demand, especially with the rise in chronic diseases and self-administration treatments.

    Growth Drivers:

    Increasing Use of Biologics: The expanding market for biologics in oncology, autoimmune, and chronic disease treatments is a major driver. Prefilled syringes are an ideal delivery system for these complex drugs.

    Rising Geriatric Population: With aging demographics across countries like Japan and China, the demand for easy-to-use, at-home injectable systems has surged.

    Healthcare Infrastructure Growth: Public and private investments in healthcare systems across emerging economies such as India, Indonesia, and Vietnam are enabling better adoption of advanced delivery devices.

    COVID-19 Aftermath: The pandemic accelerated the need for safe and efficient injectable systems, further boosting the acceptance of prefilled syringes in immunization and treatment programs.

    Opportunities:

    Expansion of Biosimilars: Increasing regulatory approvals for biosimilars across the region is creating a vast market for prefilled syringe applications.

    Technology Integration: Smart prefilled syringes with integrated tracking, dosage memory, and safety features present significant opportunities for innovation.

    Local Manufacturing: Regional governments are encouraging domestic production, presenting a major opportunity for market expansion and investment.

    U.S. Market Trends and 2024 Investments (Contextual Impact)
    In 2024, U.S.-based pharmaceutical companies increased sourcing and collaboration with Asia Pacific manufacturers to reduce supply chain vulnerabilities and lower costs. Leading pharma firms expanded partnerships with Indian and South Korean contract manufacturing organizations (CMOs) for the production of prefilled syringes intended for export markets. This influx of international investment and technology transfer into the region is helping improve manufacturing quality, accelerate regulatory alignment, and foster innovation in local production units across Asia.

    Market Segmentation – Dominant Segments
    By Type:

    Disposable Prefilled Syringes held the largest market share due to their widespread use in hospitals and vaccination programs. They are preferred for their safety, cost-effectiveness, and convenience.

    By Material:

    Glass Prefilled Syringes continue to dominate the market owing to their inert nature, drug compatibility, and established infrastructure. However, Plastic (polymer-based) syringes are rapidly gaining share due to better break-resistance and adaptability in biotech drugs.

    By Application:

    Vaccines and Autoimmune Diseases make up the largest application segment. Chronic disease management, particularly in diabetes and rheumatoid arthritis, also contributes significantly.

    Biologics & Biosimilars are rapidly expanding their footprint in both originator and generic markets.

    Competitive Analysis – Top 5 Players with Market Share Insights
    1. Becton, Dickinson and Company (BD)
    A global leader in prefilled syringe technology, BD continues to dominate the Asia Pacific market through strategic investments in local manufacturing hubs, especially in China and India. In 2024, BD launched an ultra-fine safety syringe for biologic self-administration, catering to the growing at-home care segment.

    2. Gerresheimer AG
    Gerresheimer has strengthened its presence in the region by expanding its high-tech manufacturing plant in China. The company is focused on producing customizable glass prefilled syringes and has recently introduced tamper-proof technologies.

    3. Nipro Corporation
    Japan-based Nipro is a key regional player with strong distribution across East and Southeast Asia. It has invested in automated production lines for sterile prefilled systems, catering to both pharmaceutical companies and government healthcare initiatives.

    4. Schott AG
    Schott continues to be a leading supplier of glass tubing for prefilled syringes. In 2024, it introduced a high-durability borosilicate variant designed for temperature-sensitive biologics, gaining rapid adoption in vaccine delivery.

    5. Terumo Corporation
    Terumo is a dominant supplier in Japan and South Korea. The company recently announced R&D expansion in digital-enabled prefilled systems that integrate with mobile apps for dosage tracking and patient compliance monitoring.

    These companies are not only market leaders but also at the forefront of innovation, local capacity expansion, and regulatory adaptation to meet growing regional demand.

    Regional Analysis – Country Insights
    Japan:
    As one of the most mature markets in the region, Japan accounts for a significant share in the Asia Pacific prefilled syringes market. Strong regulatory standards, aging population, and focus on self-administration have driven adoption. The Japanese government supports home healthcare and has incentivized use of prefilled systems for chronic treatments.

    China:
    With a rapidly modernizing healthcare sector and expanding domestic pharma industry, China is seeing explosive growth in the use of prefilled syringes. The “Healthy China 2030” initiative has placed emphasis on drug safety, injectable innovations, and advanced delivery systems, creating a favorable market environment.

    India:
    India’s increasing prevalence of diabetes, government-led immunization programs, and rising investments from global pharma manufacturers are propelling demand. The country’s Make-in-India initiative encourages domestic manufacturing of medical devices, including prefilled syringes.

    South Korea:
    South Korea leads in technological innovation. The government’s medical device support programs and partnerships with biotech firms have enabled the launch of smart prefilled syringes integrated with digital therapeutics.

    Australia:
    Though smaller in market size, Australia is a high-value market with stringent safety regulations. Demand is driven by chronic disease treatment and home-use biologics.

    Conclusion and Strategic Outlook
    The Asia Pacific Prefilled Syringes Market is positioned for accelerated growth over the next decade. As healthcare systems evolve, patient safety and treatment compliance become top priorities—both of which prefilled syringes are designed to address. The region’s unique blend of mature and emerging economies offers immense opportunities for both global giants and local players.



    About us

    Phase 3,Navale IT Zone, S.No. 51/2A/2,

    Office No. 202, 2nd floor,

    Near, Navale Brg,Narhe,

    Pune, Maharashtra 411041

    +91 9607365656

    [email protected]
    Asia Pacific Prefilled Syringes Market Size To Grow At A CAGR Of 11% In The Forecast Period Of 2025-2032 Asia Pacific Prefilled Syringes Market is projected to surge from USD 1.96 billion in 2023 to USD 3.41 billion by 2030, registering a CAGR of 8.3% over the forecast period. Fueled by a growing elderly population, rapid healthcare infrastructure development, and the increasing use of biologics, prefilled syringes are gaining momentum as a preferred drug delivery method across the region. Request Free Sample Report:https://www.stellarmr.com/report/req_sample/Asia-Pacific-Prefilled-Syringes-Market/1779 Market Estimation, Growth Drivers & Opportunities Prefilled syringes have become a critical part of modern healthcare due to their convenience, accuracy, sterility, and reduced risk of contamination and dosing errors. The Asia Pacific region is witnessing substantial demand, especially with the rise in chronic diseases and self-administration treatments. Growth Drivers: Increasing Use of Biologics: The expanding market for biologics in oncology, autoimmune, and chronic disease treatments is a major driver. Prefilled syringes are an ideal delivery system for these complex drugs. Rising Geriatric Population: With aging demographics across countries like Japan and China, the demand for easy-to-use, at-home injectable systems has surged. Healthcare Infrastructure Growth: Public and private investments in healthcare systems across emerging economies such as India, Indonesia, and Vietnam are enabling better adoption of advanced delivery devices. COVID-19 Aftermath: The pandemic accelerated the need for safe and efficient injectable systems, further boosting the acceptance of prefilled syringes in immunization and treatment programs. Opportunities: Expansion of Biosimilars: Increasing regulatory approvals for biosimilars across the region is creating a vast market for prefilled syringe applications. Technology Integration: Smart prefilled syringes with integrated tracking, dosage memory, and safety features present significant opportunities for innovation. Local Manufacturing: Regional governments are encouraging domestic production, presenting a major opportunity for market expansion and investment. U.S. Market Trends and 2024 Investments (Contextual Impact) In 2024, U.S.-based pharmaceutical companies increased sourcing and collaboration with Asia Pacific manufacturers to reduce supply chain vulnerabilities and lower costs. Leading pharma firms expanded partnerships with Indian and South Korean contract manufacturing organizations (CMOs) for the production of prefilled syringes intended for export markets. This influx of international investment and technology transfer into the region is helping improve manufacturing quality, accelerate regulatory alignment, and foster innovation in local production units across Asia. Market Segmentation – Dominant Segments By Type: Disposable Prefilled Syringes held the largest market share due to their widespread use in hospitals and vaccination programs. They are preferred for their safety, cost-effectiveness, and convenience. By Material: Glass Prefilled Syringes continue to dominate the market owing to their inert nature, drug compatibility, and established infrastructure. However, Plastic (polymer-based) syringes are rapidly gaining share due to better break-resistance and adaptability in biotech drugs. By Application: Vaccines and Autoimmune Diseases make up the largest application segment. Chronic disease management, particularly in diabetes and rheumatoid arthritis, also contributes significantly. Biologics & Biosimilars are rapidly expanding their footprint in both originator and generic markets. Competitive Analysis – Top 5 Players with Market Share Insights 1. Becton, Dickinson and Company (BD) A global leader in prefilled syringe technology, BD continues to dominate the Asia Pacific market through strategic investments in local manufacturing hubs, especially in China and India. In 2024, BD launched an ultra-fine safety syringe for biologic self-administration, catering to the growing at-home care segment. 2. Gerresheimer AG Gerresheimer has strengthened its presence in the region by expanding its high-tech manufacturing plant in China. The company is focused on producing customizable glass prefilled syringes and has recently introduced tamper-proof technologies. 3. Nipro Corporation Japan-based Nipro is a key regional player with strong distribution across East and Southeast Asia. It has invested in automated production lines for sterile prefilled systems, catering to both pharmaceutical companies and government healthcare initiatives. 4. Schott AG Schott continues to be a leading supplier of glass tubing for prefilled syringes. In 2024, it introduced a high-durability borosilicate variant designed for temperature-sensitive biologics, gaining rapid adoption in vaccine delivery. 5. Terumo Corporation Terumo is a dominant supplier in Japan and South Korea. The company recently announced R&D expansion in digital-enabled prefilled systems that integrate with mobile apps for dosage tracking and patient compliance monitoring. These companies are not only market leaders but also at the forefront of innovation, local capacity expansion, and regulatory adaptation to meet growing regional demand. Regional Analysis – Country Insights Japan: As one of the most mature markets in the region, Japan accounts for a significant share in the Asia Pacific prefilled syringes market. Strong regulatory standards, aging population, and focus on self-administration have driven adoption. The Japanese government supports home healthcare and has incentivized use of prefilled systems for chronic treatments. China: With a rapidly modernizing healthcare sector and expanding domestic pharma industry, China is seeing explosive growth in the use of prefilled syringes. The “Healthy China 2030” initiative has placed emphasis on drug safety, injectable innovations, and advanced delivery systems, creating a favorable market environment. India: India’s increasing prevalence of diabetes, government-led immunization programs, and rising investments from global pharma manufacturers are propelling demand. The country’s Make-in-India initiative encourages domestic manufacturing of medical devices, including prefilled syringes. South Korea: South Korea leads in technological innovation. The government’s medical device support programs and partnerships with biotech firms have enabled the launch of smart prefilled syringes integrated with digital therapeutics. Australia: Though smaller in market size, Australia is a high-value market with stringent safety regulations. Demand is driven by chronic disease treatment and home-use biologics. Conclusion and Strategic Outlook The Asia Pacific Prefilled Syringes Market is positioned for accelerated growth over the next decade. As healthcare systems evolve, patient safety and treatment compliance become top priorities—both of which prefilled syringes are designed to address. The region’s unique blend of mature and emerging economies offers immense opportunities for both global giants and local players. About us Phase 3,Navale IT Zone, S.No. 51/2A/2, Office No. 202, 2nd floor, Near, Navale Brg,Narhe, Pune, Maharashtra 411041 +91 9607365656 [email protected]
    0 Bình luận 0 Chia sẻ 1981 Lượt xem

  • Shanghai Tianlu Spring Material Co., Ltd.
    Jiangsu Tianxingjian Sports Industry Development Co., Ltd.
    HQ Add: Room 606, No.1, Lane 926, Zhenhua Road,Shanghai, P.R.China
    Tel: 0086-21-36523381/36523382 Fax: 0086-21-36523383
    Company Information
    Business Type:Manufacturer
    Location:Shanghai, China (Mainland)
    Main Products:artificial grass,landscaping grass,football turf,sports feild grass,EPDM Rubber Granules,
    polyurethane glue
    Total Employees:301 - 500 People
    Total Annual Revenue:US$10 Million - US$50 Million
    Year Established:1999
    Top 3 Markets:Asia31.67% Europe23.13% Middle East12.1%
    Factory AddressNo. 1308 Waiqian Highway, Jiading Dist, Shanghai China
    Company Profile

    Shanghai Tianlu Spring Material Co., ltd. is an diversified enterprise specializing in Artificial Grass銆丷ubber Granules and Single Component Glue . It is a leading manufacturer of professional spring materials, including R&D, manufacture, construction and design since 1999. It has gained the certificates of ISO 9001, ISO 14001, GB/T 28001 and SGS.
    We have several advanced international production lines for artificial turf. The quality of various artificial turf can fully meet the standards of FIFA certification, and has been qualified by National Sports Goods Quality Supervision and Testing Center. Besides, we got appointed the exclusive distribution of grass yarn by famous brand Korean Clone. Our artificial turf is suitable for football, golf baseball, gateball and other sports field. It is also available for landscape, villa, schools and outdoor venues. Our products are very popular in Middle East, Europe, Africa and South American, etc.
    We own several advanced production lines of EPDM Rubber Granules material, and also whole-set testing equipment. With more than 10 colorful colors, our products has been sold worldwide. Meanwhile, we have developed a new type of single-component polyurethane adhesive, which is environmentally friendly. The materials have passed the tests in the laboratory of Chinese Athletic Association and Shanghai Research Institute of Building Sciences Group. The quality of the products is excellent and stable.
    Shanghai Tianlu has formed an industrial chain of spring materials for years. Your consultation and visit are welcome, and thank you for your support all along.
    Factory Information
    Factory Size:10,000-30,000 square meters
    Factory Location: No. 1308, Waiqian Highway, Jiading District, Shanghai, P.R.China.
    No. 5 Road锛孖ndustrial Zone锛孌iduo Town锛孹inghua City, Jiangsu Province.
    Contract Manufacturing:OEM Service Offered銆丏esign Service Offered銆丅uyer Label Offered
    Annual Output Value:US$10 Million - US$50 Million
    Our Product
    Artificial Grass for Landscape銆丄rtificial Grass for Sports Field 銆丒PDM Rubber Granules銆丷ecycled Rubber Granules銆丳olyurethane Glue
    Product Application
    1銆丄rtificial Turf can be used for Sports Field, Playground, Gym, Hotel, Residential Areas, Garden, Parks, Swimming pool, Commercial Land and other Outdoor and Indoor Places.
    2銆丒PDM Rubber Granules can be used for Runway, Park, Sidewalk銆並indergarten銆両nfilling of artificial grass and other sports field.
    Our Certificate
    SGS, SGS Anti-UV Test锛孖SO 9001 , ISO 9000 , ISO 14001 , ISO 14000锛孏B/T 28001
    Production Market
    Trade & Market
    Main MarketsTotal Revenue(%)
    Asia31.67%
    Europe23.13%
    Middle East12.10%
    North America10.68%
    South America9.61%
    Africa4.98%
    Other4.98%
    Oceania2.85%
    Export Percentage:41% - 50%
    Export Mode:By agent and direct selling
    Our service
    Consultancy
    -- Consulting service makes sure that you have the most suitable products for your sports and landscape fields. Our sales team are very professional and cooperative. We鈥檒l provide you the most detailed consultation and perfect solution according to your requirement.
    Field Design
    --We offer free service for field design and installation design. Each sports or landscape field is tailor-made in our factory. We offer accurate design to make it easy for your transportation, installation and minimize the waste.
    Customization of the Products
    -- We are one of the leading manufacturer of Artificial Grass and EPDM Rubber Granules in Shanghai China. And we can produce according to your requirements.
    Logistics
    -- Wide network of Logistic service assures that the products are delivered to our clients in different countries promptly with economical solutions.
    buy Most Realistic Artificial Turf
    website:http://www.tlartificial-grass.com/
    Shanghai Tianlu Spring Material Co., Ltd. Jiangsu Tianxingjian Sports Industry Development Co., Ltd. HQ Add: Room 606, No.1, Lane 926, Zhenhua Road,Shanghai, P.R.China Tel: 0086-21-36523381/36523382 Fax: 0086-21-36523383 Company Information Business Type:Manufacturer Location:Shanghai, China (Mainland) Main Products:artificial grass,landscaping grass,football turf,sports feild grass,EPDM Rubber Granules, polyurethane glue Total Employees:301 - 500 People Total Annual Revenue:US$10 Million - US$50 Million Year Established:1999 Top 3 Markets:Asia31.67% Europe23.13% Middle East12.1% Factory AddressNo. 1308 Waiqian Highway, Jiading Dist, Shanghai China Company Profile Shanghai Tianlu Spring Material Co., ltd. is an diversified enterprise specializing in Artificial Grass銆丷ubber Granules and Single Component Glue . It is a leading manufacturer of professional spring materials, including R&D, manufacture, construction and design since 1999. It has gained the certificates of ISO 9001, ISO 14001, GB/T 28001 and SGS. We have several advanced international production lines for artificial turf. The quality of various artificial turf can fully meet the standards of FIFA certification, and has been qualified by National Sports Goods Quality Supervision and Testing Center. Besides, we got appointed the exclusive distribution of grass yarn by famous brand Korean Clone. Our artificial turf is suitable for football, golf baseball, gateball and other sports field. It is also available for landscape, villa, schools and outdoor venues. Our products are very popular in Middle East, Europe, Africa and South American, etc. We own several advanced production lines of EPDM Rubber Granules material, and also whole-set testing equipment. With more than 10 colorful colors, our products has been sold worldwide. Meanwhile, we have developed a new type of single-component polyurethane adhesive, which is environmentally friendly. The materials have passed the tests in the laboratory of Chinese Athletic Association and Shanghai Research Institute of Building Sciences Group. The quality of the products is excellent and stable. Shanghai Tianlu has formed an industrial chain of spring materials for years. Your consultation and visit are welcome, and thank you for your support all along. Factory Information Factory Size:10,000-30,000 square meters Factory Location: No. 1308, Waiqian Highway, Jiading District, Shanghai, P.R.China. No. 5 Road锛孖ndustrial Zone锛孌iduo Town锛孹inghua City, Jiangsu Province. Contract Manufacturing:OEM Service Offered銆丏esign Service Offered銆丅uyer Label Offered Annual Output Value:US$10 Million - US$50 Million Our Product Artificial Grass for Landscape銆丄rtificial Grass for Sports Field 銆丒PDM Rubber Granules銆丷ecycled Rubber Granules銆丳olyurethane Glue Product Application 1銆丄rtificial Turf can be used for Sports Field, Playground, Gym, Hotel, Residential Areas, Garden, Parks, Swimming pool, Commercial Land and other Outdoor and Indoor Places. 2銆丒PDM Rubber Granules can be used for Runway, Park, Sidewalk銆並indergarten銆両nfilling of artificial grass and other sports field. Our Certificate SGS, SGS Anti-UV Test锛孖SO 9001 , ISO 9000 , ISO 14001 , ISO 14000锛孏B/T 28001 Production Market Trade & Market Main MarketsTotal Revenue(%) Asia31.67% Europe23.13% Middle East12.10% North America10.68% South America9.61% Africa4.98% Other4.98% Oceania2.85% Export Percentage:41% - 50% Export Mode:By agent and direct selling Our service Consultancy -- Consulting service makes sure that you have the most suitable products for your sports and landscape fields. Our sales team are very professional and cooperative. We鈥檒l provide you the most detailed consultation and perfect solution according to your requirement. Field Design --We offer free service for field design and installation design. Each sports or landscape field is tailor-made in our factory. We offer accurate design to make it easy for your transportation, installation and minimize the waste. Customization of the Products -- We are one of the leading manufacturer of Artificial Grass and EPDM Rubber Granules in Shanghai China. And we can produce according to your requirements. Logistics -- Wide network of Logistic service assures that the products are delivered to our clients in different countries promptly with economical solutions. buy Most Realistic Artificial Turf website:http://www.tlartificial-grass.com/
    WWW.TLARTIFICIAL-GRASS.COM
    China Artificial Grass, woven artificial grass, hybrid grass, Rubber Granules, Polyurethane Glue Factory, Manufacturers and Suppliers - TIANLU
    TIANLU:China artificial grass, rubber granules, polyurethane glue manufacturers and suppliers. We have been specialized in producing artificial grass for years. Welcome to buy or wholesale quality products from our factory.
    0 Bình luận 0 Chia sẻ 11879 Lượt xem
Được tài trợ
Liên Hệ Quảng Cáo